KRYSKrystal Biotech, Inc.

$359.68

Is it safe?

Can KRYS take a bad year?

The deepest fall in KRYS's price history on file is −53%; it is −1.7% below its high today.

57.28

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Annualised volatility
43%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−53%

Worst drawdown on file · −1.7% today

Details
Cash and short-term investments
$846M
EBITDA, trailing twelve months
$204M
Operating profit, trailing twelve months
$198M
Annualised volatilitytwo years of daily moves
43%
Worst drawdown on file
−53%
Below its 52-week high
−1.7%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.